KIN17 activators would comprise a class of chemical compounds that modulate the activity of the protein KIN17, which is known to play roles in DNA replication, repair, and cell stress responses. KIN17 is a highly conserved protein among eukaryotes and is characterized by its ability to bind to DNA and chromatin, particularly at sites of stalled replication or DNA damage.
Direct KIN17 activators would interact with the protein at specific domains, potentially altering its structural configuration to enhance its DNA-binding affinity or its interaction with other proteins involved in DNA synthesis and repair pathways. This might increase the efficiency of the protein's participation in the recognition and processing of damaged DNA or stalled replication forks, thereby enhancing the cell's ability to maintain genomic integrity in response to stress. Indirect activators of KIN17 might affect the expression levels of the protein by modulating the transcription of the KIN17 gene, leading to increased protein synthesis. They could also act by inhibiting the degradation pathways of the protein, resulting in greater cellular accumulation and prolonged activity. Additionally, post-translational modifications such as phosphorylation, acetylation, or ubiquitination can significantly impact protein function. Indirect activators could influence these modifications, thereby altering the activity or stability of KIN17.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
Hydroxyurea inhibits ribonucleotide reductase, causing DNA replication stress. KIN17, which participates in DNA replication and repair, can be indirectly activated. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D inhibits DNA transcription, leading to DNA damage. This could potentially activate KIN17, a protein involved in DNA repair and replication. | ||||||
Rucaparib | 283173-50-2 | sc-507419 | 5 mg | $150.00 | ||
Rucaparib is a PARP inhibitor causing DNA damage, potentially leading to an increase in KIN17 activity, as it is involved in the cellular response to DNA damage. | ||||||
Olaparib | 763113-22-0 | sc-302017 sc-302017A sc-302017B | 250 mg 500 mg 1 g | $210.00 $305.00 $495.00 | 10 | |
Olaparib is another PARP inhibitor causing DNA damage. This can potentially enhance KIN17 activity, as KIN17 is involved in the DNA damage response. | ||||||